Peptides and peptide conjugates: therapeutics on the upward path.
about
Targeting the Eph System with Peptides and Peptide ConjugatesAutomated solid-phase peptide synthesis to obtain therapeutic peptidesIn silico study of peptide inhibitors against BACE 1.Combinatorial peptide libraries: mining for cell-binding peptides.Position and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues.Linker-determined drug release mechanism of free camptothecin from self-assembling drug amphiphiles.Chemerin and vaspin: possible targets to treat obesity?Cone snail venomics: from novel biology to novel therapeutics.Hapten-directed spontaneous disulfide shuffling: a universal technology for site-directed covalent coupling of payloads to antibodies.Template-constrained macrocyclic peptides prepared from native, unprotected precursorsChallenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.Harnessing supramolecular peptide nanotechnology in biomedical applications.Targeting protein arginine N-methyltransferases with peptide-based inhibitors: opportunities and challenges.Modulating protein-protein interactions: the potential of peptides.Review cyclic peptides on a merry-go-round; towards drug design.Controlling toxicity of Peptide-drug conjugates by different chemical linker structures.Use of the site-specific retargeting jump-in platform cell line to support biologic drug discovery.Peptide modifications differentially alter G protein-coupled receptor internalization and signaling bias.Peptibodies: An elegant solution for a long-standing problem.Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.Development of Potent and Metabolically Stable APJ Ligands with High Therapeutic Potential.Stabilization of peptides against proteolysis through disulfide-bridged conjugation with synthetic aromatics.Access to site-specific Fc-cRGD peptide conjugates through streamlined expressed protein ligation.Molecular design and synthesis of self-assembling camptothecin drug amphiphiles.Therapeutic peptides.Peptide-guided functionalization and macrocyclization of bioactive peptidosulfonamides by Pd(II)-catalyzed late-stage C-H activationModel peptides containing the 3-sulfanyl-norbornene amino acid, a conformationally constrained cysteine analogue effective inducer of 310-helix secondary structures
P2860
Q26799461-48FED175-91DD-4E1E-8E99-92EF612AA01BQ27001623-7EA42253-7DE6-4217-9471-20D7800DD41BQ30374668-F41500EE-5CFA-4D50-A12D-8367791F288AQ31144876-D386174D-6CBA-465A-89DC-993ABC5D7079Q33919544-7CCFCF6E-2615-4779-AB98-E21464A7C63EQ34159575-A1D23DDF-C4EC-4B1C-B84D-A0D3D806C3DBQ34529446-DBD32226-BD5F-447A-B038-4919065E7692Q35432836-59899484-0911-4FB5-AFEF-81172BDB23EBQ35555148-3ACCF7FA-7641-47DB-9681-016EBFF31337Q37218436-53285DAA-1420-4134-8FC5-EBDB8C7CEF31Q37360619-6D367D57-FE42-4B91-80B1-94967985FD70Q37643461-3040F6BB-9801-4F20-B412-9F89F38D8AEBQ38164844-74AA5400-11B8-4F80-A2D7-D8DADE709228Q38314370-6C4C03A2-731D-4234-A973-991B2E4A9497Q38476515-D330F9CC-4B58-421F-A2F3-CE92F38AFFDBQ38882129-B8CCE159-821E-42C1-9BF3-15C09113A2F8Q38926027-E748B7E2-C89F-440A-9B56-2D9AD955EEC6Q42031030-7881FEAD-5A05-424F-93D6-B61FC7C2D156Q47229048-AFA53E18-066D-48C3-9D03-2D83DC060FA4Q48089546-5056C955-8412-44EB-9198-10AB07E0183FQ48097017-7B5BD5B8-F5B4-49E2-B785-B9810BDACB1BQ48263291-F702882D-497B-4DC9-B03B-686975BCDF2BQ48310799-ABCC2464-57BB-4B57-9249-3BA8B5442C12Q50682565-6445F1FC-11A4-41C4-AAF8-0B9F136C48EAQ51564495-AB10456A-C005-4A24-9537-EFE88CA2C931Q58714785-FDA25519-CE00-4868-808F-9BE3DE5F9096Q58857788-ED41DD8C-EBEC-4E4E-8C17-6F2C19B3B96F
P2860
Peptides and peptide conjugates: therapeutics on the upward path.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Peptides and peptide conjugates: therapeutics on the upward path.
@en
type
label
Peptides and peptide conjugates: therapeutics on the upward path.
@en
prefLabel
Peptides and peptide conjugates: therapeutics on the upward path.
@en
P2093
P2860
P356
P1476
Peptides and peptide conjugates: therapeutics on the upward path.
@en
P2093
Annette G Beck-Sickinger
Kathrin Bellmann-Sickert
Verena M Ahrens
P2860
P304
P356
10.4155/FMC.12.76
P577
2012-08-01T00:00:00Z